Ligand validation:3VT7

VDX: 5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL

VDX is a Ligand Of Interest in 3VT7 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VT7_VDX_A_500	84%	16%	0.103	0.966	2.01	1.67	10	10	0	0	100%	1
1RK3_VDX_A_500	80%	5%	0.106	0.956	3.21	2.29	18	16	1	0	100%	1
3VT3_VDX_A_500	68%	19%	0.137	0.949	1.96	1.53	11	6	1	0	100%	1
5H1E_VDX_A_501	50%	35%	0.193	0.944	1.07	1.47	1	10	2	0	100%	1
2ZLC_VDX_A_500	42%	16%	0.221	0.942	2.14	1.58	12	8	2	0	100%	1
7QPP_VDX_A_501	91%	9%	0.08	0.966	2.17	2.27	9	14	0	0	100%	1
1IE9_VDX_A_500	90%	26%	0.073	0.955	1.2	1.8	2	12	0	1	100%	1
6XZK_VDX_A_501	81%	6%	0.097	0.949	2.89	2.26	11	12	0	0	100%	1
6XZJ_VDX_A_501	80%	5%	0.113	0.962	2.9	2.45	11	14	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.